Generating thermostabilized agonist-bound GPR40/FFAR1 using virus-like particles and a label-free binding assay
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Generating thermostabilized agonist-bound GPR40/FFAR1 using virus-like particles and a label-free binding assay
Authors
Keywords
-
Journal
MOLECULAR MEMBRANE BIOLOGY
Volume 31, Issue 5, Pages 168-175
Publisher
Informa UK Limited
Online
2014-07-28
DOI
10.3109/09687688.2014.923588
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Loss of constitutive activity is correlated with increased thermostability of the human adenosine A2Areceptor
- (2013) Nicolas Bertheleme et al. BRITISH JOURNAL OF PHARMACOLOGY
- Molecular signatures of G-protein-coupled receptors
- (2013) A. J. Venkatakrishnan et al. NATURE
- A Novel Antidiabetic Drug, Fasiglifam/TAK-875, Acts as an Ago-Allosteric Modulator of FFAR1
- (2013) Chiori Yabuki et al. PLoS One
- A Multiple-Ascending-Dose Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of a Novel GPR40 Agonist, TAK-875, in Subjects With Type 2 Diabetes
- (2012) E Leifke et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Discovery of 1,2,4-Triazine Derivatives as Adenosine A2A Antagonists using Structure Based Drug Design
- (2012) Miles Congreve et al. JOURNAL OF MEDICINAL CHEMISTRY
- TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial
- (2012) Charles F Burant et al. LANCET
- Fusion Partner Toolchest for the Stabilization and Crystallization of G Protein-Coupled Receptors
- (2012) Eugene Chun et al. STRUCTURE
- A crystal clear solution for determining G-protein-coupled receptor structures
- (2012) Christopher G. Tate TRENDS IN BIOCHEMICAL SCIENCES
- GPR40-induced insulin secretion by the novel agonist TAK-875: first clinical findings in patients with type 2 diabetes
- (2011) T. Araki et al. DIABETES OBESITY & METABOLISM
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Properties of the GPR40 Agonist TAK-875: Results From a Double-Blind, Placebo-Controlled Single Oral Dose Rising Study in Healthy Volunteers
- (2011) Himanshu Naik et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Engineering an Ultra-Thermostable β1-Adrenoceptor
- (2011) Jennifer L. Miller et al. JOURNAL OF MOLECULAR BIOLOGY
- Thermostabilisation of an Agonist-Bound Conformation of the Human Adenosine A2A Receptor
- (2011) Guillaume Lebon et al. JOURNAL OF MOLECULAR BIOLOGY
- Structure of the Adenosine A2A Receptor in Complex with ZM241385 and the Xanthines XAC and Caffeine
- (2011) Andrew S. Doré et al. STRUCTURE
- The properties of thermostabilised G protein-coupled receptors (StaRs) and their use in drug discovery
- (2010) Nathan Robertson et al. NEUROPHARMACOLOGY
- Thermostabilization of the Neurotensin Receptor NTS1
- (2009) Yoko Shibata et al. JOURNAL OF MOLECULAR BIOLOGY
- Structure-based discovery of 2-adrenergic receptor ligands
- (2009) P. Kolb et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural diversity of G protein-coupled receptors and significance for drug discovery
- (2008) Malin C. Lagerström et al. NATURE REVIEWS DRUG DISCOVERY
- Co-evolving stability and conformational homogeneity of the human adenosine A2a receptor
- (2008) F. Magnani et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Conformational thermostabilization of the 1-adrenergic receptor in a detergent-resistant form
- (2008) M. J. Serrano-Vega et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started